BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE (EIN 953432210) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1979

Legal Domicile

Phone

6262564673

Tax Period

2023-10-01 to 2024-09-30

BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE, founded in 1979, is a major nonprofit in the Medical Research sector that reported $285.3M in total revenue in fiscal year 2023. Revenue surged 25% from the prior year, signaling strong growth momentum. Expenses of $382.5M exceeded revenue, resulting in a 34% operating deficit.

Mission

TO DISCOVER AND TRANSLATE INNOVATIVE LABORATORY FINDINGS INTO NEW CLINICAL TREATMENTS BY USING PRACTICAL APPLICATIONS OF CHEMISTRY, PHYSICS AND BIOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $165,812,985

Program Service Revenue $19,939,417

Investment Income $83,859,993

Other Revenue $15,702,922

TOTAL REVENUE $285,315,317

Expense Breakdown

Grants Paid $1,633,728

Salaries & Benefits $215,680,736

Fundraising Expenses $97,952

Program Expenses $324,818,769

Other Expenses $165,138,092

TOTAL EXPENSES $382,452,556

Year-over-Year Comparison

	2023	2022	Change
Revenue	$285,315,317	$229,086,534	+0.2%
Expenses	$382,452,556	$353,496,343	+0.1%
Net Income	$-97,137,239	$-124,409,809	-0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

1177

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$10,266,180

Total Directors

$457,019

Key Employees

$10,537,370

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Steven B Fink	Director & Chair of the Board	2.0	Officer Director	$0	$0	$0
Charlotte Hubbert PhD	Director	2.0	Director	$0	$0	$0
Debbie C Thurmond	Director/Professor	60.0	Director	$435,306	$21,713	$457,019
Emmet Stephenson	Director	2.0	Director	$0	$0	$0
Julian Husbands MD	Director	2.0	Director	$0	$0	$0
Norman Payson MD	Director	2.0	Director	$0	$0	$0
Saro Armenian DO MPH	Director/Professor	2.0	Director	$0	$0	$0
Selwyn Isakow	Director	2.0	Director	$0	$0	$0
Stephanie Okey	Director	2.0	Director	$0	$0	$0
Todd M Binder	Director	2.0	Director	$0	$0	$0
Cristin J O'Callahan	General Counsel & Corp Secretary	10.0	Officer	$186,671	$341,125	$1,472,464
Donald J Matthewson	Assistant Treasurer	12.0	Officer	$125,464	$12,060	$639,380
Jo Ann Escasa-Haigh	Chief Business Officer	12.0	Officer	$365,936	$150,513	$1,980,192
Robert W Stone	President & CEO	4.0	Officer	$300,338	$1,667,332	$6,149,982
Yvette Tremonti	Treasurer/Chief Financial Officer	10.0	Officer	$0	$24,162	$24,162
Ashley Baker Lee	SVP, Research Operations	48.0	Key Emp	$872,074	$132,846	$1,222,938
David A Horne	Vice Prvst & Depty Dir BRI & Dn Fac Aff	60.0	Key Emp	$914,413	$104,799	$1,019,212
David Craig	Dep Dir, Integr Transltnl Sci	60.0	Key Emp	$428,774	$14,702	$443,476
Debra F Fields	Exec VP & Chief Transformation Ofc	12.0	Key Emp	$340,881	$384,116	$2,088,520
John D Carpten	Chf Sci Off, BRI Dir, Canc Ctr Dir	33.0	Key Emp	$571,428	$100,957	$1,139,917
Marcellus R Van Den Brink MD PhD	Pres COH LA & NMC & Chf Phys Exec	6.0	Key Emp	$99,787	$157,403	$1,155,272
Mark Hulse	Chief Digital Officer	12.0	Key Emp	$276,672	$42,307	$1,425,667
Steven Terry Rosen MD	EVP, Dir Emeritus Comp Canc Ctr & BRI	54.0	Key Emp	$1,562,947	$305,760	$2,042,368
Edward S Kim	Director, System Clin Trials	15.0	Highest	$396,461	$136,190	$1,722,035
Harlan Alcon Levine	Pres, Hlth Innovation & Policy	11.0	Highest	$364,681	$403,546	$2,392,717
Kristin Bertell	Chief Philanthropy Officer	2.0	Highest	$41,469	$314,901	$1,558,973
Larry Kwak	Deputy Dir, Comp Cancer Ctr	60.0	Highest	$1,040,975	$51,025	$1,092,000
Vijay Trisal MD	System Chief Clinical Officer	2.0	Highest	$37,057	$148,148	$1,259,854
Jennifer Parkhurst	Former Officer	12.0		$312,857	$64,845	$1,629,131
Philip Okala	FORMER OFFICER	12.0		$175,540	$14,345	$892,045

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$285,315,317	$382,452,556	$2,184,814,083	$-97,137,239
2023	$229,086,534	$353,496,343	$1,946,470,774	$-124,409,809
2022	$288,276,013	$367,599,613	$1,755,270,549	$-79,323,600
2021	$339,177,936	$341,846,245	$1,995,828,082	$-2,668,309
2020	$266,229,786	$368,392,601	$1,692,642,628	$-102,162,815
2019	$568,398,026	$426,095,842	$1,556,201,710	$142,302,184
2018	$585,400,050	$433,936,266	$1,472,757,241	$151,463,784

BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE